Advertisement

The Cerebellum

, Volume 18, Issue 1, pp 76–84 | Cite as

PSP-Phenotype in SCA8: Case Report and Systemic Review

  • Makoto Samukawa
  • Makito HiranoEmail author
  • Kazumasa Saigoh
  • Shigeru Kawai
  • Yukihiro Hamada
  • Daisuke Takahashi
  • Yusaku Nakamura
  • Susumu Kusunoki
Original Paper

Abstract

Spinocerebellar ataxia type 8 (SCA8) is a rare autosomal dominant neurodegenerative disease caused by expanded CTA/CTG repeats in the ATXN8OS gene. Many patients had pure cerebellar ataxia, while some had parkinsonism, both without causal explanation. We analyzed the ATXN8OS gene in 150 Japanese patients with ataxia and 76 patients with Parkinson’s disease or related disorders. We systematically reassessed 123 patients with SCA8, both our patients and those reported in other studies. Two patients with progressive supranuclear palsy (PSP) had mutations in the ATXN8OS gene. Systematic analyses revealed that patients with parkinsonism had significantly shorter CTA/CTG repeat expansions and older age at onset than those with predominant ataxia. We show the imaging results of patients with and without parkinsonism. We also found a significant inverse relationship between repeat sizes and age at onset in all patients, which has not been detected previously. Our results may be useful to genetic counseling, improve understanding of the pathomechanism, and extend the clinical phenotype of SCA8.

Keywords

Spinocerebellar ataxia type 8 CTA/CTG repeats Triplet repeat Intermediate expansion Parkinsonism 

Notes

Acknowledgments

The authors thank Dr. Abe of the Department of Neurology, Okayama University, for technical assistance in the analysis of the NOP56 gene causative for SCA36.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author Contributions

1. Design or conceptualization of the study.

2. Acquisition of the data.

3. Analysis or interpretation of the data.

4. Drafting or revising the manuscript for intellectual content.

Dr. Makoto Samukawa has contributed to 1, 2, and 3.

Dr. Makito Hirano has contributed to 2, 3, and 4.

Dr. Kazumasa Saigoh has contributed to 2, 3, and 4.

Dr. Shigeru Kawai has contributed to 2, 3, and 4.

Dr. Yukihiro Hamada has contributed to 2, 3, and 4.

Dr. Daisuke Takahashi has contributed to 2, 3, and 4.

Dr. Yusaku Nakamura has contributed to 1, 3, and 4.

Dr. Susumu Kusunoki has contributed to 1, 3, and 4.

Compliance with Ethical Standards

Conflict of Interest

None of the authors have any conflict of interest, including financial, personal, or other relationships with other people or organizations within 3 years since beginning the work submitted that could inappropriately influence (bias) our work.

Supplementary material

12311_2018_955_MOESM1_ESM.docx (38 kb)
ESM 1 (DOCX 37 kb)
12311_2018_955_MOESM2_ESM.jpg (30 kb)
Supplemental figure 1 Age at examination and repeat size in unaffected individuals with CTA/CTG repeat expansions in the ATXN8OS gene (unaffected). Patients with SCA8 (affected) were grouped according to their repeat sizes every ten repeats, and the oldest age at onset among the groups was also plotted. Only approximately 20% of unaffected individuals were older than the oldest age of patients with similar repeat sizes. (JPG 29 kb)

References

  1. 1.
    Koob MD, Moseley ML, Schut LJ, Benzow KA, Bird TD, Day JW, et al. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat Genet. 1999;21:379–84.  https://doi.org/10.1038/7710.CrossRefPubMedGoogle Scholar
  2. 2.
    Day JW, Schut LJ, Moseley ML, Durand AC, Ranum LP. Spinocerebellar ataxia type 8: clinical features in a large family. Neurology. 2000;55:649–57.CrossRefGoogle Scholar
  3. 3.
    Baba Y, Uitti RJ, Farrer MJ, Wszolek ZK. Sporadic SCA8 mutation resembling corticobasal degeneration. Parkinsonism Relat Disord. 2005;11:147–50.  https://doi.org/10.1016/j.parkreldis.2004.10.008.CrossRefPubMedGoogle Scholar
  4. 4.
    Wu YR, Chen IC, Soong BW, Kao SH, Lee GC, Huang SY, et al. SCA8 repeat expansion: large CTA/CTG repeat alleles in neurological disorders and functional implications. Hum Genet. 2009;125:437–44.  https://doi.org/10.1007/s00439-009-0641-x.CrossRefPubMedGoogle Scholar
  5. 5.
    Miyawaki T, Sekiguchi K, Yasui N, Ueda T, Kanda F, Toda T. A case of juvenile parkinsonism with expanded SCA8 CTA/CTG repeats. Rinsho Shinkeigaku. 2013;53:278–82.CrossRefGoogle Scholar
  6. 6.
    Koga S, Josephs KA, Ogaki K, Labbe C, Uitti RJ, Graff-Radford N, et al. Cerebellar ataxia in progressive supranuclear palsy: an autopsy study of PSP-C. Mov Disord. 2016;31:653–62.  https://doi.org/10.1002/mds.26499.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Moseley ML, Zu T, Ikeda Y, Gao W, Mosemiller AK, Daughters RS, et al. Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat Genet. 2006;38:758–69.  https://doi.org/10.1038/ng1827.CrossRefPubMedGoogle Scholar
  8. 8.
    Ikeda Y, Dalton JC, Moseley ML, Gardner KL, Bird TD, Ashizawa T, et al. Spinocerebellar ataxia type 8: molecular genetic comparisons and haplotype analysis of 37 families with ataxia. Am J Hum Genet. 2004;75:3–16.  https://doi.org/10.1086/422014.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Ayhan F, Ikeda Y, Dalton JC, Day JW and Ranum LPW. Spinocerebellar ataxia type 8. In: R. A. Pagon, M. P. Adam, H. H. Ardinger, S. E. Wallace, A. Amemiya, L. J. H. Bean, T. D. Bird, C. T. Fong, H. C. Mefford, R. J. H. Smith and K. Stephens, editors. GeneReviews(R). Seattle (WA); 1993.Google Scholar
  10. 10.
    Hirano M, Matsumura R, Nakamura Y, Saigoh K, Sakamoto H, Ueno S, et al. Unexpectedly mild phenotype in an ataxic family with a two-base deletion in the APTX gene. J Neurol Sci. 2017;378:75–9.  https://doi.org/10.1016/j.jns.2017.04.049.CrossRefPubMedGoogle Scholar
  11. 11.
    Ogaki K, Li Y, Takanashi M, Ishikawa K, Kobayashi T, Nonaka T, et al. Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS. Parkinsonism Relat Disord. 2013;19:15–20.CrossRefGoogle Scholar
  12. 12.
    Kobayashi H, Ujike H, Hasegawa J, Yamamoto M, Kanzaki A, Sora I. Correlation of tau gene polymorphism with age at onset of Parkinson’s disease. Neurosci Lett. 2006;405:202–6.  https://doi.org/10.1016/j.neulet.2006.06.057.CrossRefPubMedGoogle Scholar
  13. 13.
    Asai H, Hirano M, Shimada K, Kiriyama T, Furiya Y, Ikeda M, et al. Protein kinase C gamma, a protein causative for dominant ataxia, negatively regulates nuclear import of recessive-ataxia-related aprataxin. Hum Mol Genet. 2009;18:3533–43.  https://doi.org/10.1093/hmg/ddp298.CrossRefPubMedGoogle Scholar
  14. 14.
    Factor SA, Qian J, Lava NS, Hubbard JD, Payami H. False-positive SCA8 gene test in a patient with pathologically proven multiple system atrophy. Ann Neurol. 2005;57:462–3.  https://doi.org/10.1002/ana.20389.CrossRefPubMedGoogle Scholar
  15. 15.
    Worth PF, Houlden H, Giunti P, Davis MB, Wood NW. Large, expanded repeats in SCA8 are not confined to patients with cerebellar ataxia. Nat Genet. 2000;24:214–5.  https://doi.org/10.1038/73411.CrossRefPubMedGoogle Scholar
  16. 16.
    Izumi Y, Maruyama H, Oda M, Morino H, Okada T, Ito H, et al. SCA8 repeat expansion: large CTA/CTG repeat alleles are more common in ataxic patients, including those with SCA6. Am J Hum Genet. 2003;72:704–9.  https://doi.org/10.1086/367775.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Silveira I, Alonso I, Guimaraes L, Mendonca P, Santos C, Maciel P, et al. High germinal instability of the (CTG)n at the SCA8 locus of both expanded and normal alleles. Am J Hum Genet. 2000;66:830–40.  https://doi.org/10.1086/302827.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Cellini E, Nacmias B, Forleo P, Piacentini S, Guarnieri BM, Serio A, et al. Genetic and clinical analysis of spinocerebellar ataxia type 8 repeat expansion in Italy. Arch Neurol. 2001;58:1856–9.CrossRefGoogle Scholar
  19. 19.
    Corral J, Genis D, Banchs I, San Nicolas H, Armstrong J, Volpini V. Giant SCA8 alleles in nine children whose mother has two moderately large ones. Ann Neurol. 2005;57:549–53.  https://doi.org/10.1002/ana.20421.CrossRefPubMedGoogle Scholar
  20. 20.
    Brusco A, Cagnoli C, Franco A, Dragone E, Nardacchione A, Grosso E, et al. Analysis of SCA8 and SCA12 loci in 134 Italian ataxic patients negative for SCA1–3, 6 and 7 CAG expansions. J Neurol. 2002;249:923–9.  https://doi.org/10.1007/s00415-002-0760-y.CrossRefPubMedGoogle Scholar
  21. 21.
    Zeman A, Stone J, Porteous M, Burns E, Barron L, Warner J. Spinocerebellar ataxia type 8 in Scotland: genetic and clinical features in seven unrelated cases and a review of published reports. J Neurol Neurosurg Psychiatry. 2004;75:459–65.CrossRefGoogle Scholar
  22. 22.
    Juvonen V, Hietala M, Paivarinta M, Rantamaki M, Hakamies L, Kaakkola S, et al. Clinical and genetic findings in Finnish ataxia patients with the spinocerebellar ataxia 8 repeat expansion. Ann Neurol. 2000;48:354–61.CrossRefGoogle Scholar
  23. 23.
    Topisirovic I, Dragasevic N, Savic D, Ristic A, Keckarevic M, Keckarevic D, et al. Genetic and clinical analysis of spinocerebellar ataxia type 8 repeat expansion in Yugoslavia. Clin Genet. 2002;62:321–4.CrossRefGoogle Scholar
  24. 24.
    Tazon B, Badenas C, Jimenez L, Munoz E, Mila M. SCA8 in the Spanish population including one homozygous patient. Clin Genet. 2002;62:404–9.CrossRefGoogle Scholar
  25. 25.
    Schols L, Bauer I, Zuhlke C, Schulte T, Kolmel C, Burk K, et al. Do CTG expansions at the SCA8 locus cause ataxia? Ann Neurol. 2003;54:110–5.  https://doi.org/10.1002/ana.10608.CrossRefPubMedGoogle Scholar
  26. 26.
    Hoglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord. 2017;32:853–64.  https://doi.org/10.1002/mds.26987.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Koide R, Ikeuchi T, Onodera O, Tanaka H, Igarashi S, Endo K, et al. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet. 1994;6:9–13.  https://doi.org/10.1038/ng0194-9.CrossRefPubMedGoogle Scholar
  28. 28.
    Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069–75.  https://doi.org/10.1038/nature09320.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Johnson KA, Sperling RA, Holman BL, Nagel JS, Growdon JH. Cerebral perfusion in progressive supranuclear palsy. J Nucl Med. 1992;33:704–9.PubMedGoogle Scholar
  30. 30.
    O'Donnell WT, Warren ST. A decade of molecular studies of fragile X syndrome. Annu Rev Neurosci. 2002;25:315–38.  https://doi.org/10.1146/annurev.neuro.25.112701.142909.CrossRefPubMedGoogle Scholar
  31. 31.
    Matsumura R, Futamura N, Fujimoto Y, Yanagimoto S, Horikawa H, Suzumura A, et al. Spinocerebellar ataxia type 6. Molecular and clinical features of 35 Japanese patients including one homozygous for the CAG repeat expansion. Neurology. 1997;49:1238–43.CrossRefGoogle Scholar
  32. 32.
    Botta A, Rinaldi F, Catalli C, Vergani L, Bonifazi E, Romeo V, et al. The CTG repeat expansion size correlates with the splicing defects observed in muscles from myotonic dystrophy type 1 patients. J Med Genet. 2008;45:639–46.  https://doi.org/10.1136/jmg.2008.058909.CrossRefPubMedGoogle Scholar
  33. 33.
    Kearse MG, Todd PK. Repeat-associated non-AUG translation and its impact in neurodegenerative disease. Neurotherapeutics. 2014;11:721–31.  https://doi.org/10.1007/s13311-014-0292-z.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Makoto Samukawa
    • 1
  • Makito Hirano
    • 1
    • 2
    Email author
  • Kazumasa Saigoh
    • 1
  • Shigeru Kawai
    • 1
  • Yukihiro Hamada
    • 1
    • 2
  • Daisuke Takahashi
    • 3
  • Yusaku Nakamura
    • 2
  • Susumu Kusunoki
    • 1
  1. 1.Department of Neurology, Faculty of MedicineKindai UniversityOsakaJapan
  2. 2.Department of NeurologyKindai University Sakai HospitalOsakaJapan
  3. 3.Department of Vascular NeurologyNational Hospital Organization Osaka Minami Medical CenterOsakaJapan

Personalised recommendations